Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.42 |
| ▸ | F10 | P00742 | 11/20 | 0.39 |
| ▸ | MAOB | P27338 | 3/20 | 0.38 |
| ▸ | CALML3 | P27482 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | SDHA | P31040 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6489857 | 0.91 | MAOA (0.44) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6489859 | 0.91 | MAOA (0.44) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6240757 | 0.88 | MAOA (0.44) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6240753 | 0.88 | MAOA (0.44) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6210396 | 0.88 | MAOA (0.55) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6211814 | 0.88 | MAOA (0.44) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6257851 | 0.86 | MAOA (0.46) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6214218 | 0.86 | MAOA (0.45) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6210943 | 0.86 | MAOA (0.45) | MAOAF10MAOBCALML3LMNA | |
| SCHEMBL6213161 | 0.85 | MAOA (0.46) | MAOAF10MAOBCALML3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1594865-A2 | ANTIBACTERIAL AGENTS | Warner-Lambert Company LLC (US) | 2005-11-16 | — | — | EP | disclosed |
| WO-2004069832-A2 | ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2004-08-19 | — | — | WO | disclosed |